EUS Intervention Stents


PSY-Pseudocysts Stent

Highlights:

  • Wide acute Flares to prevent migration.
  • Large stent diameter to perform safe & easy retrieval of pancreatic necrosis.

EUS Guided

1) Choledochal Duodenostomy
2) Hepatic Gastrostomy

Highlights:

  • Finned design to prevent outward & wide proximal flare to prevent inward migration.
  • Re-capturing property: up to 80% during deployment.

Tracheobronchial Stents

TracheoBronchial "Y" Stents

Double Lock Design

  • Additional support for cartilaginous airway.
  • Reduce chance of Stent fractures.

Highlights:

  • Reduce disruption of the mucocilliary elevator via Reinforced Posterior Stents Membrane design.
  • Additional Gold radiopaque markers for ease of deployment under fluoroscopy guidance.

Bravo™ TracheoBronchial Stent

Indicated for patient with the Treacheobronchial stenosis by inoperable lung cancer or luminal stenosis caused by extrinsic compression of the mediastinal mass as well as the Trachea-esophageal fistula by lung cancer or Esophageal cancer.

Highlights:

  • Nitinol Mesh with Atraumatic Ends.
  • Segmental Radial Force.
  • Repositioning Lasso on both distal and proximal ends.

GI Application Stents

Honto™ Colorectal Stent

Indicated for pre-operative obstruction relief prior to planned surgery for removal of Colo-rectal Carcinoma.

Highlights:

  • Gold radiopaque markers on each end and Centre of stent for good visibility.
  • 9 radiopaque markers present an excellent view.
  • Minimized shortening rate to prevent dislocating of the stent.

Honto™ Pyloric/ Duodenal stent

Indicated for malignant gastric outlet obstruction.

Highlights:

  • Gold radiopaque markers on each end and centre of stent for good visibility.
  • 9 radiopaque markers present an excellent view.
  • Minimized shortening rate to prevent dislocating of the stent.

Honto™ Biliary Stent

Made of Nitinol wire designed to maintain patency of the bile duct strictures caused by malignant tumors’.

Highlights:

  • Gold radiopaque markers on each end and centre of stent for good visibility.
  • 9 radiopaque markers present an excellent view.
  • Minimized shortening rate to prevent dislocating of the stent.

Honto™ Pancreatic Stent

Indicated for pancreatic pseudocyst drainage.

Highlights:

  • Large and acute angled flared at both ends to prevent the risk of migration. Allows accurate positioning within stomach & cyst wall.
  • Hybrid-S coating to prevent leakage and tissue in growth. 
  • Slippery inner covering to assist in drainage of viscous liquid from pancreatic abscess’.

Bravo™ Urethral Stent

Indicated for Recurrent Bulbar Urethral Strictures (RBUS), benign prostatic hyperplasia (BPH).

Highlights:

  • Fully covered design with Hybrid-S coating (Silicon) to prevent tumour in growth.
  • Proximal end lasso to ensure safety in easy removal of stent.
  • 12fr. Catheter size for easy passage through the therapeutic ureteroscopy to perform deployment under endoscopy vision.

Bravo™ Esophageal Stent

The stent is indicated for palliative treatment of upper Gastrointestinal Neoplasm in patients with unrespectable, gastric carcinoma and also in pre-operative patients for correction of dysphagia.

Highlights:

  • 9 radiopaque markers present an excellent view.
  • Larger heads on the both ends prevent the stent from migration.
  • Hybrid-S coating for smooth and reliable food passage with tumour growth prevention.